Health Discovery | GenomeWeb

Health Discovery

People In The News

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Health Discovery Corporation has named John Norris to be its new CEO, taking over the helm from Stephen Barnhill, who founded the company and has been its chairman and CEO for nine years.

NEW YORK (GenomeWeb News) – The US Patent and Trademark Office intends to issue a re-examination certificate to Intel for a patent that is at the center of a dispute between the computer chip manufacturer and personalized medicine firm Health Discovery.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Health Discovery Corporation today announced it has filed a request for the reexamination of a patent held by Intel with applications for the identification of disease genes.

IP Roundup

Premium

National Taiwan University, NanoString Technologies, Agilent Technologies, Asuragen, Children's Hospital & Research Center, Corning, Advanced Liquid Logic, Health Discovery

Pairings

Premium

Duane Morris, Thomas Gallagher

People In the News

Ivan Trifunovich is now CEO at Helicos, NIH staff is elected to IOM, Richard Scott Tobin has stepped down from all positions at Health Discovery Corp., and more

The firm also raised around $1.7 million through a warrant conversion tied to a 2007 private placement.

In a letter to shareholders, the company said that it is nearing completion of certain milestones, and as a result should be eligible for the $250,000 payment by the end of the year.

The suit stems from the issuance of purchase warrants that were part of a September 2007 private placement.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.